Case Studies in Diabetes: Escalating treatment with combination dulaglutide and insulin

Australie

$0

gratuit

RACGP CPD Program

30 min

Endocrinology

1 Credits

This course is expired! Browse All Courses
APPRENDRE ENCORE PLUS

Description du cours

This latest panel discussion reviews new opportunities in the management of type-2 diabetes brought about by recent changes to the RACGP/ADS guidelines and new PBS reimbursement criteria, particularly with regard to combination therapies.

The video is framed around 2 case studies, which are discussed by the panellists.

This program is supported by an independent educational grant provided from Eli Lilly.

Détails du cours

Date d'expiration : 2022-08-09

Métiers: Médecin

Faculté

Dr Anita Sharma, General Practitioner, Queensland. 

Dr Ted Wu, Director of the Diabetes Centre, Royal Prince Alfred Hospital.  

Prof Richard MacIsaac, Professor and Director of Endocrinology & Diabetes, St Vincent’s Health.

Accréditation

Members are able to claim CPD activity points for 1 points through ‘Quick log’ on their RACGP CPD Dashboard.

Objectif(s) d'apprentissage

This panel discussion is designed to enable participants to be better able to:

  • Recognise the new PBS reimbursement criteria for use of GLP1-RAs in combination with insulin 
  • Identifier ideal patient profiles for concomitant use of insulin with respect to achieving glycaemic control and CV benefit 
  • Discuss the clinical benefits of concomitant use of GLP1-RAs and insulin with patients 
This course is expired! Browse All Courses